Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Featured Research Sessions - Next-Generation Neuroimaging: Monitoring Treatments and Disease Progression
  • Featured Research Sessions
  • Tau Pathology Interferes With Amyloid Removal By Gantenerumab
  • Victoria 5/6
    Set Timezone

Matteo Tonietto1, Erica Silvestri2,3, Anton Belousov4, Luka Kulic1, Janice Smith5, Gregory Klein6,3.
1Research and Early Development (pRED), Hoffmann-La Roche, BASEL, Switzerland, 2A4P Consulting Ltd, Sandwich, United Kingdom, 3Research and Early Development (pRED), Hoffmann-La Roche, Basel, Switzerland, 4Roche Products Ltd, Hoffmann-La Roche, BASEL, Switzerland, 5Roche Products Ltd, Hoffmann-La Roche, Welwyn Garden City, United Kingdom, 6
Types
Main Session